Cargando…
Tissue plasminogen activator (tPA) in the management of predominantly hemorrhagic age-related macular degeneration, milligram/milliliter or microgram/milliliter?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267534/ https://www.ncbi.nlm.nih.gov/pubmed/22291455 http://dx.doi.org/10.2147/OPTH.S28071 |
| _version_ | 1782222291085557760 |
|---|---|
| author | Boone, Niels Willem van Leeuwen, Roelof Wouter Frederik |
| author_facet | Boone, Niels Willem van Leeuwen, Roelof Wouter Frederik |
| author_sort | Boone, Niels Willem |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3267534 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | Dove Medical Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-32675342012-01-30 Tissue plasminogen activator (tPA) in the management of predominantly hemorrhagic age-related macular degeneration, milligram/milliliter or microgram/milliliter? Boone, Niels Willem van Leeuwen, Roelof Wouter Frederik Clin Ophthalmol Letter Dove Medical Press 2012 2012-01-19 /pmc/articles/PMC3267534/ /pubmed/22291455 http://dx.doi.org/10.2147/OPTH.S28071 Text en © 2012 Boone and van Leeuwen, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
| spellingShingle | Letter Boone, Niels Willem van Leeuwen, Roelof Wouter Frederik Tissue plasminogen activator (tPA) in the management of predominantly hemorrhagic age-related macular degeneration, milligram/milliliter or microgram/milliliter? |
| title | Tissue plasminogen activator (tPA) in the management of predominantly hemorrhagic age-related macular degeneration, milligram/milliliter or microgram/milliliter? |
| title_full | Tissue plasminogen activator (tPA) in the management of predominantly hemorrhagic age-related macular degeneration, milligram/milliliter or microgram/milliliter? |
| title_fullStr | Tissue plasminogen activator (tPA) in the management of predominantly hemorrhagic age-related macular degeneration, milligram/milliliter or microgram/milliliter? |
| title_full_unstemmed | Tissue plasminogen activator (tPA) in the management of predominantly hemorrhagic age-related macular degeneration, milligram/milliliter or microgram/milliliter? |
| title_short | Tissue plasminogen activator (tPA) in the management of predominantly hemorrhagic age-related macular degeneration, milligram/milliliter or microgram/milliliter? |
| title_sort | tissue plasminogen activator (tpa) in the management of predominantly hemorrhagic age-related macular degeneration, milligram/milliliter or microgram/milliliter? |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267534/ https://www.ncbi.nlm.nih.gov/pubmed/22291455 http://dx.doi.org/10.2147/OPTH.S28071 |
| work_keys_str_mv | AT boonenielswillem tissueplasminogenactivatortpainthemanagementofpredominantlyhemorrhagicagerelatedmaculardegenerationmilligrammilliliterormicrogrammilliliter AT vanleeuwenroelofwouterfrederik tissueplasminogenactivatortpainthemanagementofpredominantlyhemorrhagicagerelatedmaculardegenerationmilligrammilliliterormicrogrammilliliter |